Thomas S. Y. Chan

1.8k citations
24 papers · 982 indexed · 1 hit paper · h-index 13
Topics
Lymphoma Diagnosis and Treatment (7 papers)Fungal Infections and Studies (5 papers)Cytomegalovirus and herpesvirus research (5 papers)
Partner nations
ChinaHong KongSingapore

In The Last Decade

Thomas S. Y. Chan

23 papers receiving 968 citations

Hit Papers

PD1 blockade with pembrolizumab is highly effective in re...20172026202020232017100200300

Peers

Thomas S. Y. Chan
Comparison fields: 5 of 71
  • Oncology 461
  • Pathology and Forensic Medicine 397
  • Epidemiology 351
  • Immunology 308
  • Hepatology 198
Replace Luis Marı́n with:
Luis Marı́n Spain
CK Lee South Korea
Deborah Woodworth United States
I. Wichmann Spain
A. Grigg Australia
M. Bunce United Kingdom
Thomas Griga Germany
S Sugai Japan
T Ohnoshi Japan
Marjorie Bernstein-Singer United States
Thomas S. Y. Chan relative to Luis Marı́n Spain Luis Marı́n's profile →
Citations per field
00.5×4.5×
Luis Marı́n · 1×
Citations per year

Countries citing papers authored by Thomas S. Y. Chan

Since Specialization
Citations

This map shows the geographic impact of Thomas S. Y. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas S. Y. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas S. Y. Chan more than expected).

Fields of papers citing papers by Thomas S. Y. Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas S. Y. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas S. Y. Chan. The network helps show where Thomas S. Y. Chan may publish in the future.

Co-authorship network of co-authors of Thomas S. Y. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas S. Y. Chan. A scholar is included among the top collaborators of Thomas S. Y. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas S. Y. Chan. Thomas S. Y. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 3
4 23
5 2
6 10
7 44
8 21
9
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginasebreakdown →
359
10 44
11 13
12 25
13 56
14 14
15 64
16 3
17 17
18 9
19
Novel therapeutic agents for T-cell lymphomas.
5
20 5

About Thomas S. Y. Chan

Thomas S. Y. Chan is a scholar working on Hematology, Pathology and Forensic Medicine and Ophthalmology, having authored 24 papers that have together received 982 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Fungal Infections and Studies (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). The work is most often cited by research in Hepatology (198 citations), Pathology and Forensic Medicine (397 citations) and Oncology (461 citations). Thomas S. Y. Chan has collaborated with scholars based in China, Hong Kong and Singapore. Frequent co-authors include Yok‐Lam Kwong, Eric Tse, Pek‐Lan Khong, Yu‐Yan Hwang, Harinder Gill, Florence Loong, Colin Phipps, Daryl Tan, Seok Jin Kim and Rex Au-Yeung. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026